REFERENCE
Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D.Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. British Journal of Psychiatry 195: 170-177, No. 2, Aug 2009
Rights and permissions
About this article
Cite this article
The EQ-5D should be considered for use in future cost-effectiveness studies. Pharmacoecon. Outcomes News 587, 4 (2009). https://doi.org/10.2165/00151234-200905870-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905870-00010